SLC12A1 and kidney disorder: Consequently, these findings may open up new avenues in studying the ER and Golgi quality control of NKCC2 proteins in order to help in the development of new strategies to prevent and/or treat kidney disorders related to aberrant NKCC2 trafficking and expression.